RedHill Biopharma's stock surged on Nasdaq following the divestment of its Talicia business to Apotex for $18M, while future products seek FDA approval.
1 report, 1 independent
Updated Aug 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
RedHill Biopharma's stock surged on Nasdaq following the divestment of its Talicia business to Apotex for $18M, while future products seek FDA approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
- FDA
-
Apotex
Canadian private pharmaceutical company
Nothing else this week.
Related events
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.
- FDA granted accelerated approval for VOCERYQ, causing INOVIO stock to lead Nasdaq gainers.
- Market summary on August 5, 2026, noting strong earnings reports from companies and analyzing Nasdaq's performance and trends.